From LifeSiteNews

By Calvin Freiburger

A jury ruled that Blue Cross Blue Shield of Michigan committed religious discrimination against 30-year IT specialist and Catholic Lisa Domski when it denied her a religious accommodation from the company’s COVID shot mandate.

A former IT specialist for Blue Cross Blue Shield has been awarded $12 million in damages and lost wages for her lawsuit over being fired for refusing the COVID-19 shot, in a major victory for religious liberty.

Newsweek reports that the insurance company fired 30-year employee Lisa Domski in 2021 after she sought a religious exemption to their jab mandate and was turned down. The insurer reportedly questioned the sincerity of her religious objections as a Catholic, but denied religious discrimination in the trial. 

Domski further maintained that the rationale behind mandating the shot didn’t apply in her case, as 75% of her work was remote before the pandemic and had shifted to fully remote during it, meaning she could not possibly have endangered others even if the shot did prevent transmission, which has since been admitted to not be the case.

“Our forefathers fought and died for the freedom for each American to practice his or her own religion,” declared her attorney Jon Marko. “Neither the government nor a corporation has a right to force an individual to choose between his or her career and conscience. Lisa refused to renounce her faith and beliefs and was wrongfully terminated from the only job she had ever known. The jury’s verdict today tells [Blue Cross Blue Shield of Michigan] that religious discrimination has no place in America and affirms each person’s right to religious freedom.”

In response, the company said it was “disappointed” in the jury verdict and would be “reviewing its legal options and will determine its path forward in the coming days.”

Many religious and pro-life Americans like Lisa Domski have a moral objection to using medical products whose existence is owed in some way to abortion.

According to a detailed overview by the pro-life Charlotte Lozier Institute, Pfizer, Moderna, and Johnson & Johnson all used aborted fetal cells during their vaccines’ testing phase; and Johnson & Johnson also used the cells during the design and development and production phases. The American Association for the Advancement of Science’s journal Science has admitted the same, and even the left-wing fact-checking outlet Snopes acknowledges the statement “that such cell lines were used in the development of COVID-19 vaccines is accurate.”

Moral qualms are just one of the reasons for the ongoing controversy, next to a large body of evidence identifying significant risks to the COVID shots, which were developed and reviewed in a fraction of the time vaccines usually take under the first Trump administration’s Operation Warp Speed initiative.

The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,068 deaths, 218,646 hospitalizations, 22,002 heart attacks, and 28,706 myocarditis and pericarditis cases as of October 25, among other ailments. U.S. Centers for Disease Control & Prevention (CDC) researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.

An analysis of 99 million people across eight countries published February in the journal Vaccine  “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID shots, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 jabs and offered several theories for a causal link.

All eyes are currently on former President Donald Trump, who last week won his campaign to return to the White House and whose team has given mixed signals as to the prospects of reconsidering the shots for which he has long taken credit. At the very least, Trump has consistently opposed mandating them and is expected to fill more federal judicial vacancies with jurists favorably inclined to the rights of employees in similar lawsuits.

Meanwhile, some hope that legal action can succeed in bringing accountability on the issue by legally targeting the companies for misrepresentation rather than their products directly. In Florida, an ongoing grand jury investigation into the shots’ manufacturers is slated to release a highly anticipated report on the injections, and a lawsuit by the state of Kansas has been filed accusing Pfizer of fraud for calling the shots “safe and effective.”